特定的SOX10增强元件调节黑色素瘤的表型可塑性和耐药性
Sophia Noah DeGeorgia1, Charles K Kaufman1
1Division of Medical Oncology, Department of Medicine and Department of Developmental Biology, Washington University in Saint Louis, St. Louis, MO USA.
bioRxiv : the preprint server for biology
|January 7, 2025
概括
黑色素瘤的耐药性和侵入性源于转录性可塑性. 控制SOX10表达的增强元件关键驱动黑色素瘤细胞身份转移和耐药性,提供新的治疗点.
科学领域:
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
- 转录条例 转录条例 转录条例
背景情况:
- 黑色素瘤的进展和耐药性越来越多地与转录性可塑性有关,而不仅仅是基因突变.
- 了解黑色素瘤中的细胞身份转移对于开发有效的癌症疗法至关重要.
- 控制黑色素瘤表型状态转换的机制尚不清楚.
研究的目的:
- 研究驱动黑色素瘤细胞可塑性和耐药性的转录控制元素.
- 确定调节黑色素瘤中SOX10表达的关键增强剂.
- 探索针对SOX10调节和NTRK1.1的治疗潜力.
主要方法:
- 利用斑马鱼黑色素瘤模型进行转录控制元素的高通量分析.
- 识别和特征斑马鱼SOX10增强剂.
- 使用CRISPR-Cas9来删除黑色素瘤细胞系中的人类SOX10增强元件.
主要成果:
- 确定了从斑马鱼到人类黑色素瘤的可翻译增强剂特征.
- 发现了两个对SOX10表达至关重要的人类SOX10上游增强剂.
- 这些增强剂的CRISPR-Cas9删除诱导了表型转变和药物耐药性增加,上调NTRK1.
结论:
- SOX10增强剂元素在黑色素瘤表型可塑性和耐药性中起着至关重要的作用.
- NTRK1上调与增强剂驱动的表型转变和药物耐药性有关.
- 准SOX10调节和NTRK1为黑色素瘤治疗提供了一个有希望的策略.
相关概念视频
Pleiotropy
39.7K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
39.7K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K


